02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 67.05
+0.22%Margins
Gross margin
68.2%
EBITDA margin
-63.6%
EBIT margin
-74.6%
Net margin
92.9%
FCF margin
-104.3%
19.1%
Return on equity
13.5%
Return on assets
-13.1%
Return on invested capital
0.17x
Asset turnover
-HKD 701.6M
Cash from operations
HKD 13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026